
doi: 10.1007/bf02789123
pmid: 24271561
Normal and neoplastic cells (like nonpathogenic and pathogenic microorganisms) apparently have similar needs and tolerances for iron, but neoplastic cells (like pathogenic microorganisms) may exhibit altered mechanisms of iron acquisition that permit continued growth in host iron-restricted tissues. Excess iron tends to interfere with host defense against malignant cells (as well as against microbial invaders); severe iron deficiency may likewise be detrimental. Elevated temperature is more toxic towards neoplastic than to normal host cells; it is not yet known whether the site of action of heat might be associated with iron acquisition (as has been demonstrated for gram negative bacteria). Persons or animals with iron overload tend to be at greater risk than normal hosts in the development of neoplasms.Construction of animal models of iron overload, although difficult, is strongly indicated at this time. Based on such models, decisions then can be made about the extent to which (a) nutritional immunity against neoplastic cells is practiced by vertebrate hosts and (b) clinical procedures could be employed to strengthen such immunity as an adjunct to radiotherapy, chemotherapy, and surgery.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 63 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
